CAREDX, INC. Comprehensive Income
CAREDX, INC. (CDNA) reported Comprehensive Income of $116.91 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2026-07-30
- CAREDX, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-06-30 was $116.91M.
- CAREDX, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-03-31 was $2.05M.
- CAREDX, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-12-31 was -$3.67M, a 104.25% decline year-over-year.
- CAREDX, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-09-30 was $1.83M.
- CAREDX, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2025 was -$18.30M, a 135.92% decline from fiscal 2024.
- CAREDX, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2024 was $50.94M.
- CAREDX, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2023 was -$189.74M.
- CAREDX, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was -$79.45M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $116.91M 10-Q · filed 2026-07-30 | $118.96M 10-Q · filed 2026-07-30 | $115.29M derived: sum of 3 quarters · filed 2026-07-30 | $117.13M derived: sum of 4 quarters · filed 2026-07-30 | |||
| 2026-03-31 | $2.05M 10-Q · filed 2026-04-28 | -$1.62M derived: sum of 2 quarters · filed 2026-04-28 | $217.00K derived: sum of 3 quarters · filed 2026-04-28 | -$7.38M derived: sum of 4 quarters · filed 2026-07-30 | |||
| 2025-12-31 | -$3.67M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$1.83M derived: sum of 2 quarters · filed 2026-02-25 | -$9.43M derived: sum of 3 quarters · filed 2026-07-30 | -$18.30M 10-K · filed 2026-02-25 | |||
| 2025-09-30 | $1.83M 10-Q · filed 2025-11-04 | -$5.76M derived: sum of 2 quarters · filed 2026-07-30 | -$14.63M 10-Q · filed 2025-11-04 | $71.67M derived: sum of 4 quarters · filed 2026-07-30 | |||
| 2025-06-30 | -$7.59M 10-Q · filed 2026-07-30 | -$16.46M 10-Q · filed 2026-07-30 | $69.84M derived: sum of 3 quarters · filed 2026-07-30 | $59.99M derived: sum of 4 quarters · filed 2026-07-30 | |||
| 2025-03-31 | -$8.87M 10-Q · filed 2026-04-28 | $77.43M derived: sum of 2 quarters · filed 2026-04-28 | $67.58M derived: sum of 3 quarters · filed 2026-04-28 | $63.10M derived: sum of 4 quarters · filed 2026-04-28 | |||
| 2024-12-31 | $86.31M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $76.45M derived: sum of 2 quarters · filed 2026-02-25 | $71.98M derived: sum of 3 quarters · filed 2026-02-25 | $50.94M 10-K · filed 2026-02-25 | |||
| 2024-09-30 | -$9.85M 10-Q · filed 2025-11-04 | -$6.62M 10-Q · filed 2024-11-04 | -$14.33M derived: sum of 2 quarters · filed 2025-11-04 | -$35.36M 10-Q · filed 2025-11-04 | -$25.68M 10-Q · filed 2024-11-04 | -$151.75M derived: sum of 4 quarters · filed 2026-02-25 | |
| 2024-06-30 | -$4.48M 10-Q · filed 2025-08-06 | -$1.25M 10-Q · filed 2024-07-31 | -$25.51M 10-Q · filed 2025-08-06 | -$19.05M 10-Q · filed 2024-07-31 | -$141.90M derived: sum of 3 quarters · filed 2026-02-25 | -$165.61M derived: sum of 4 quarters · filed 2026-02-25 | |
| 2024-03-31 | -$21.03M 10-Q · filed 2025-04-30 | -$17.80M 10-Q · filed 2024-05-09 | -$137.42M derived: sum of 2 quarters · filed 2026-02-25 | -$161.13M derived: sum of 3 quarters · filed 2026-02-25 | -$187.09M derived: sum of 4 quarters · filed 2026-02-25 | ||
| 2023-12-31 | -$116.39M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$140.09M derived: sum of 2 quarters · filed 2026-02-25 | -$166.06M derived: sum of 3 quarters · filed 2026-02-25 | -$189.74M 10-K · filed 2026-02-25 | |||
| 2023-09-30 | -$23.70M 10-Q · filed 2024-11-04 | -$49.67M derived: sum of 2 quarters · filed 2024-11-04 | -$73.35M 10-Q · filed 2024-11-04 | -$90.38M derived: sum of 4 quarters · filed 2025-02-28 | |||
| 2023-06-30 | -$25.96M 10-Q · filed 2024-07-31 | -$49.65M 10-Q · filed 2024-07-31 | -$66.67M derived: sum of 3 quarters · filed 2025-02-28 | -$85.24M derived: sum of 4 quarters · filed 2025-02-28 | |||
| 2023-03-31 | -$23.68M 10-Q · filed 2024-05-09 | -$40.71M derived: sum of 2 quarters · filed 2025-02-28 | -$59.27M derived: sum of 3 quarters · filed 2025-02-28 | -$83.06M derived: sum of 4 quarters · filed 2025-02-28 | |||
| 2022-12-31 | -$17.02M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | -$35.59M derived: sum of 2 quarters · filed 2025-02-28 | -$59.38M derived: sum of 3 quarters · filed 2025-02-28 | -$79.45M 10-K · filed 2025-02-28 | |||
| 2022-09-30 | -$18.57M 10-Q · filed 2023-11-08 | -$42.35M derived: sum of 2 quarters · filed 2023-11-08 | -$62.42M 10-Q · filed 2023-11-08 | -$79.15M derived: sum of 4 quarters · filed 2024-02-28 | |||
| 2022-06-30 | -$23.79M 10-Q · filed 2023-08-08 | -$43.86M 10-Q · filed 2023-08-08 | -$60.59M derived: sum of 3 quarters · filed 2024-02-28 | -$73.42M derived: sum of 4 quarters · filed 2024-02-28 | |||
| 2022-03-31 | -$20.07M 10-Q · filed 2023-05-10 | -$36.80M derived: sum of 2 quarters · filed 2024-02-28 | -$49.63M derived: sum of 3 quarters · filed 2024-02-28 | -$51.11M derived: sum of 4 quarters · filed 2024-02-28 | |||
| 2021-12-31 | -$16.73M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | -$29.56M derived: sum of 2 quarters · filed 2024-02-28 | -$31.05M derived: sum of 3 quarters · filed 2024-02-28 | -$33.24M 10-K · filed 2024-02-28 | |||
| 2021-09-30 | -$12.83M 10-Q · filed 2022-11-03 | -$14.32M derived: sum of 2 quarters · filed 2022-11-03 | -$16.51M 10-Q · filed 2022-11-03 | -$17.77M derived: sum of 4 quarters · filed 2023-02-27 | |||
| 2021-06-30 | -$1.48M 10-Q · filed 2022-08-04 | -$3.67M 10-Q · filed 2022-08-04 | -$4.93M derived: sum of 3 quarters · filed 2023-02-27 | -$6.79M derived: sum of 4 quarters · filed 2023-02-27 | |||
| 2021-03-31 | -$2.19M 10-Q · filed 2022-05-05 | -$3.45M derived: sum of 2 quarters · filed 2023-02-27 | -$5.30M derived: sum of 3 quarters · filed 2023-02-27 | -$10.27M derived: sum of 4 quarters · filed 2023-02-27 | |||
| 2020-12-31 | -$1.26M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | -$3.12M derived: sum of 2 quarters · filed 2023-02-27 | -$8.08M derived: sum of 3 quarters · filed 2023-02-27 | -$15.61M 10-K · filed 2023-02-27 | |||
| 2020-09-30 | -$1.86M 10-Q · filed 2021-10-28 | -$6.82M derived: sum of 2 quarters · filed 2021-10-28 | -$14.35M 10-Q · filed 2021-10-28 | -$18.39M derived: sum of 4 quarters · filed 2021-10-28 | |||
| 2020-06-30 | -$4.96M 10-Q · filed 2021-07-29 | -$12.49M 10-Q · filed 2021-07-29 | -$16.54M derived: sum of 3 quarters · filed 2021-07-29 | -$19.21M derived: sum of 4 quarters · filed 2021-07-29 | |||
| 2020-03-31 | -$7.53M 10-Q · filed 2021-05-05 | -$11.58M derived: sum of 2 quarters · filed 2021-05-05 | -$14.25M derived: sum of 3 quarters · filed 2021-05-05 | -$22.17M derived: sum of 4 quarters · filed 2021-05-05 | |||
| 2019-12-31 | -$4.05M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | -$6.72M derived: sum of 2 quarters · filed 2021-02-24 | -$14.64M derived: sum of 3 quarters · filed 2021-02-24 | -$22.89M 10-K · filed 2021-02-24 | |||
| 2019-09-30 | -$2.68M 10-Q · filed 2020-10-29 | -$10.59M derived: sum of 2 quarters · filed 2020-10-29 | -$18.85M 10-Q · filed 2020-10-29 | -$22.89M derived: sum of 4 quarters · filed 2021-02-24 | |||
| 2019-06-30 | -$7.92M 10-Q · filed 2020-08-04 | -$16.17M 10-Q · filed 2020-08-04 | -$20.22M derived: sum of 3 quarters · filed 2021-02-24 | -$40.07M derived: sum of 4 quarters · filed 2021-02-24 | |||
| 2019-03-31 | -$8.26M 10-Q · filed 2020-04-30 | -$12.30M derived: sum of 2 quarters · filed 2021-02-24 | -$32.15M derived: sum of 3 quarters · filed 2021-02-24 | -$47.84M derived: sum of 4 quarters · filed 2021-02-24 | |||
| 2018-12-31 | -$4.05M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | -$23.90M derived: sum of 2 quarters · filed 2021-02-24 | -$39.58M derived: sum of 3 quarters · filed 2021-02-24 | -$48.69M 10-K · filed 2021-02-24 | |||
| 2018-09-30 | -$19.85M 10-Q · filed 2019-10-31 | -$19.85M 10-Q · filed 2018-11-08 | -$35.54M derived: sum of 2 quarters · filed 2019-10-31 | -$44.64M 10-Q · filed 2019-10-31 | -$44.65M 10-Q · filed 2018-11-08 | -$76.47M derived: sum of 4 quarters · filed 2020-02-28 | |
| 2018-06-30 | -$15.69M 10-Q · filed 2019-08-01 | -$24.79M 10-Q · filed 2019-08-01 | -$56.62M derived: sum of 3 quarters · filed 2020-02-28 | -$70.36M derived: sum of 4 quarters · filed 2020-02-28 | |||
| 2018-03-31 | -$9.11M 10-Q · filed 2019-05-08 | -$40.93M derived: sum of 2 quarters · filed 2020-02-28 | -$54.67M derived: sum of 3 quarters · filed 2020-02-28 | -$57.97M derived: sum of 4 quarters · filed 2020-02-28 | |||
| 2017-12-31 | -$31.83M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | -$45.57M derived: sum of 2 quarters · filed 2020-02-28 | -$48.86M derived: sum of 3 quarters · filed 2020-02-28 | -$54.16M 10-K · filed 2020-02-28 | |||
| 2017-09-30 | -$13.74M 10-Q · filed 2018-11-08 | -$17.03M derived: sum of 2 quarters · filed 2018-11-08 | -$22.33M 10-Q · filed 2018-11-08 | -$39.63M derived: sum of 4 quarters · filed 2019-03-06 | |||
| 2017-06-30 | -$3.29M 10-Q · filed 2018-08-09 | -$8.59M 10-Q · filed 2018-08-09 | -$25.89M derived: sum of 3 quarters · filed 2019-03-06 | -$30.08M derived: sum of 4 quarters · filed 2019-03-06 | |||
| 2017-03-31 | -$5.29M 10-Q · filed 2018-05-10 | -$22.60M derived: sum of 2 quarters · filed 2019-03-06 | -$26.79M derived: sum of 3 quarters · filed 2019-03-06 | -$38.67M derived: sum of 4 quarters · filed 2019-03-06 | |||
| 2016-12-31 | -$17.31M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | -$21.50M derived: sum of 2 quarters · filed 2019-03-06 | -$33.37M derived: sum of 3 quarters · filed 2019-03-06 | -$43.13M 10-K · filed 2019-03-06 | |||
| 2016-09-30 | -$4.19M 10-Q · filed 2017-11-09 | -$16.07M derived: sum of 2 quarters · filed 2017-11-09 | -$25.82M 10-Q · filed 2017-11-09 | -$30.58M derived: sum of 4 quarters · filed 2018-03-22 | |||
| 2016-06-30 | -$11.88M 10-Q · filed 2017-08-11 | -$21.63M 10-Q · filed 2017-08-11 | -$26.39M derived: sum of 3 quarters · filed 2018-03-22 | -$29.88M derived: sum of 4 quarters · filed 2018-03-22 | |||
| 2016-03-31 | -$9.75M 10-Q · filed 2017-06-09 | -$14.51M derived: sum of 2 quarters · filed 2018-03-22 | -$18.00M derived: sum of 3 quarters · filed 2018-03-22 | -$21.19M derived: sum of 4 quarters · filed 2018-03-22 | |||
| 2015-12-31 | -$4.76M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-22 | -$8.25M derived: sum of 2 quarters · filed 2018-03-22 | -$11.44M derived: sum of 3 quarters · filed 2018-03-22 | -$13.71M 10-K · filed 2018-03-22 | |||
| 2015-09-30 | -$3.49M 10-Q · filed 2016-11-14 | -$6.67M derived: sum of 2 quarters · filed 2016-11-14 | -$8.95M 10-Q · filed 2016-11-14 | ||||
| 2015-06-30 | -$3.19M 10-Q · filed 2016-08-22 | -$5.46M 10-Q · filed 2016-08-22 | |||||
| 2014-12-31 | $781.00K 10-K · filed 2017-04-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |